Skip to main content
Log in

Behavioral effects of alpha2 adrenoceptor antagonists and their interactions with ethanol in tests of locomotion, exploration and anxiety in mice

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

The behavioral effects of two highly selective alpha2-adrenoceptor antagonists, atipamezole and idazoxan, were investigated in mice using the plusmaze test of anxiety and the holeboard test of directed exploration and locomotor activity. No anxiogenic effect, as assessed by the tendency to enter the closed as opposed to open arms of the plusmaze, was noted for either drug at any dose tested. Neither were there any significant effects on locomotor activity or directed exploration (head-dipping) in the holeboard, or total plusmaze arm entries at any dose of either drug. The co-administration of either atipamezole or idazoxan had no effect on either the anxiolytic effect of ethanol (2 g/kg) or its locomotor stimulant effect in the holeboard. Atipamezole (1.0 and 3.0 mg/kg) significantly reversed the ethanol-induced reduction in exploratory head-dipping; a similar trend was seen for idazoxan. There was also a significant potentiation of the ethanol-induced increase in the number of total arm entries made on the plusmaze caused by 1.0 mg/kg (but not 3.0 mg/kg) atipamezole and both 0.3 and 1.0 mg/kg idazoxan. The results suggest that some of the behavioral effects of ethanol can be reversed by alpha2-adrenoceptor antagonists whilst others are unchanged.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Charney DS, Heninger GR, Redmond DE (1983) Yohimbine induced anxiety and increased noradrenergic function in humans: effects of diazepam and clonidine. Life Sci 33:19–29

    Google Scholar 

  • Dorow R, Horowski R, Paschelelke G, Amin M, Braestrup C (1983) Severe anxiety induced by FG 7142, a beta-carboline ligand for benzodiazepine receptors. Lancet II:98–99

    Google Scholar 

  • Dunn RW, Fielding S (1987) Yohimbine-induced seizures in mice: a model predictive of potential anxiolytic and GABA-mimetic agents. Drug Dev Res 10:177–188

    Google Scholar 

  • Durcan MJ, Lister RG (1988a) Does directed exploration influence locomotor activity in the holeboard test? Behav Neural Biol (in press)

  • Durcan MJ, Lister RG (1988b) The time course of ethanol's effects on activity, exploration and anxiety in the mouse. Psychopharmacology 96:67–72

    Google Scholar 

  • Durcan MJ, Lister RG, Linnoila M (1988a) Interactions of alpha2-adrenoceptor antagonists with medetomidine and with ethanol in a holeboard test. Neuropharmacology (in press)

  • Durcan MJ, Lister RG, Linnoila M (1988b) Interactions of the alpha2-adrenoceptor antagonist, atipamezole, with ethanol on exploration and locomotor activity. Soc Neurosci Abstr 14 (in press)

  • File SE (1987) The contribution of behavioral studies to the neuropharmacology of anxiety. Neuropharmacology 26:877–886

    Google Scholar 

  • File SE, Wardill AG (1975) Validity of head-dipping as a measure of exploration in a modified holeboard. Psychopharmacology 44:53–59

    Google Scholar 

  • File SE, Lister RG, Nutt DJ (1982) The anxiogenic action of benzodiazepine antagonists. Neuropharmacology 21:1033–1037

    Google Scholar 

  • Handley SL, Mithani S (1984) Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of “fear”-motivated behavior. Naunyn-Schmiedeberg's Arch Pharmacol 327:1–5

    Google Scholar 

  • Holmberg G, Gershon S (1961) Autonomic and psychic effects of yohimbine hydrochloride. Psychopharmacologia 2:93–106

    Google Scholar 

  • Idemundia SO, Mathis DA, Lal H (1987) Enhancement of a diazepam withdrawal symptom by bicuculline and yohimbine. Neuropharmacology 26:1739–1743

    Google Scholar 

  • Lal H, Shearman GT, Bennet D (1983) Yohimbine: a betacarboline with behavioral and neurochemical properties common to anxiogenic drugs. Soc Neurosci Abstr 9:437

    Google Scholar 

  • Lister RG (1987) The use of the plusmaze to measure anxiety in the mouse. Psychopharmacology 92:180–185

    Google Scholar 

  • Lister RG (1988) Interactions of three benzodiazepine receptor inverse agonists with ethanol in a plus-maze test of anxiety. Pharmacol Biochem Behav 30:701–706

    Google Scholar 

  • Pellow S, Chopin P, Briley M, File SE (1985a) The validation of open: closed arm entries in an elevated plus-maze measure of anxiety in the rat. J Neurosci Methods 14:149–167

    Google Scholar 

  • Pellow S, Chopin P, File SE (1985b) Are the anxiogenic effects of yohimbine in the social interaction test mediated at benzodiazepine receptors? Neurosci Lett 55:5–9

    Google Scholar 

  • Petersen EN, Jensen LH, Honore T, Braestrup C (1983) Differential pharmacological effects of benzodiazepines receptor inverse agonists. In: Biggio G, Costa E (eds) Benzodiazepine recognition site ligands: biochemistry and pharmacology. Raven Press, New York, pp 57–64

    Google Scholar 

  • Scheinin H, McDonald E, Scheinin M (1988) Behavioral and neurochemical effects of atipamezole, a novel alpha2-adrenoceptor antagonist. Eur J Pharmacol 151:35–42

    Google Scholar 

  • Soderpalm B, Engel JA (1988) Biphasic effects of clonidine on conflict behavior: involvement of different alpha-adrenoceptors. Pharmacol Biochem Behav 30:471–477

    Google Scholar 

  • Virtanen R, Savola J-M, Saano V (1988) Atipamezole (MPV-1248), a potent, selective and specific alpha2-adrenoceptor antagonist. Br J Pharmacol (in press)

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Durcan, M.J., Lister, R.G. & Linnoila, M. Behavioral effects of alpha2 adrenoceptor antagonists and their interactions with ethanol in tests of locomotion, exploration and anxiety in mice. Psychopharmacology 97, 189–193 (1989). https://doi.org/10.1007/BF00442248

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00442248

Key words

Navigation